CA948642A - Phenazone-paracetamol complex - Google Patents

Phenazone-paracetamol complex

Info

Publication number
CA948642A
CA948642A CA070,544A CA70544A CA948642A CA 948642 A CA948642 A CA 948642A CA 70544 A CA70544 A CA 70544A CA 948642 A CA948642 A CA 948642A
Authority
CA
Canada
Prior art keywords
phenazone
paracetamol
complex
paracetamol complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA070,544A
Other languages
English (en)
Inventor
Barbara A. Johnson
Frank Ridgway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of CA948642A publication Critical patent/CA948642A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA070,544A 1969-01-13 1969-12-22 Phenazone-paracetamol complex Expired CA948642A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB193569 1969-01-13

Publications (1)

Publication Number Publication Date
CA948642A true CA948642A (en) 1974-06-04

Family

ID=9730621

Family Applications (1)

Application Number Title Priority Date Filing Date
CA070,544A Expired CA948642A (en) 1969-01-13 1969-12-22 Phenazone-paracetamol complex

Country Status (5)

Country Link
CA (1) CA948642A (https=)
CH (1) CH507253A (https=)
DE (1) DE2000210A1 (https=)
FR (1) FR2034467B1 (https=)
GB (1) GB1297261A (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10130504B4 (de) 2001-06-25 2005-02-03 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
WO2004000284A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
CA2477923C (en) * 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen

Also Published As

Publication number Publication date
FR2034467B1 (https=) 1974-04-12
DE2000210A1 (de) 1970-07-23
GB1297261A (https=) 1972-11-22
FR2034467A1 (https=) 1970-12-11
CH507253A (fr) 1971-05-15

Similar Documents

Publication Publication Date Title
CA918701A (en) Connecteur sous-marin
AU1304370A (en) Altenators
CA948642A (en) Phenazone-paracetamol complex
AU1550770A (en) Jackstrip
AU1707970A (en) Rotocyclone
AU1812170A (en) 14b-hydroxy-15-acyloxy-cardenolides
AU1646670A (en) d-18-METHYL-17d-ALKYNYL-4-OESTREN-17b-OLS
CA977372A (en) Phenylthiobenzylamines
AU446111B2 (en) Electromagmet
CA909737A (en) Port-bagages
AU6286569A (en) Catheter-needle
AU1739070A (en) Quinoxaline-din-oxide-hydroxy-lactone
CA814460A (en) Bismuth-chlorhydroxyquinoline complex
CA803535A (en) 2-alkylaminobenzimidazoles
CA828200A (en) 2-alkoxy-4-substituted-benzylamines
CA807691A (en) Phosphonothionates
CA808693A (en) Alkoxy-trifluoromethylphenalkylamines
CA809651A (en) 8-azasteroids
CA809680A (en) Haloethersiloxanes
CA817426A (en) 1-hydrazino-adamantan
CA819744A (en) 1-aryl-3-lower-alkylamino-pyrrolidines
CA812818A (en) Pyrazinamidoguanidine
CA821314A (en) Electro-precipitation
CA822121A (en) Pyridyl-2-phenylbenzocycloalkenes
CA803537A (en) Des-a steroides